Cellerant to Present at the International Society for Stem Cell Research (ISSCR) 10th Annual Meeting in Japan
09:00 EDT 15 Jun 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Cellerant Therapeutics Inc., a biotechnology company developing novel
hematopoietic stem cell-based cellular and antibody therapies for blood
disorders and cancer, announced today that Cellerant’s President and
CEO, Ram Mandal...
Other Sources for this Article
Cellerant Therapeutics, Inc.
Jun Yoon, 650-232-2122
Executive
Director, Corporate Development
info@cellerant.com
More From BioPortfolio on "Cellerant to Present at the International Society for Stem Cell Research (ISSCR) 10th Annual Meeting in Japan"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
